PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.45%
Positive revenue growth while 3391.T is negative. John Neff might see a notable competitive edge here.
8.06%
Positive gross profit growth while 3391.T is negative. John Neff would see a clear operational edge over the competitor.
14.43%
Positive EBIT growth while 3391.T is negative. John Neff might see a substantial edge in operational management.
17.38%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
50.76%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
50.77%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
50.77%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.29%
Dividend growth of 35.29% while 3391.T is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
6.12%
OCF growth at 75-90% of 3391.T's 6.81%. Bill Ackman would demand better working capital management or cost discipline.
6.12%
FCF growth 75-90% of 3391.T's 6.81%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
25.67%
10Y revenue/share CAGR under 50% of 3391.T's 178.41%. Michael Burry would suspect a lasting competitive disadvantage.
50.38%
5Y revenue/share CAGR above 1.5x 3391.T's 27.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
15.60%
3Y revenue/share CAGR above 1.5x 3391.T's 10.27%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
64.86%
Net income/share CAGR above 1.5x 3391.T's 19.41% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
30.47%
Positive 5Y CAGR while 3391.T is negative. John Neff might view this as a strong mid-term relative advantage.
4.42%
Positive short-term CAGR while 3391.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
134.80%
10Y equity/share CAGR at 75-90% of 3391.T's 161.56%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
93.84%
5Y equity/share CAGR above 1.5x 3391.T's 43.74%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
44.89%
3Y equity/share CAGR above 1.5x 3391.T's 17.92%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
283.33%
Similar 10Y dividend/share CAGR to 3391.T's 258.75%. Walter Schloss expects both to share consistent earnings expansions and payout practices.
155.56%
5Y dividend/share CAGR above 1.5x 3391.T's 88.82%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
91.67%
3Y dividend/share CAGR above 1.5x 3391.T's 54.30%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
32.94%
AR growth well above 3391.T's 0.18%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.47%
We show growth while 3391.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
11.68%
Asset growth above 1.5x 3391.T's 2.32%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.71%
BV/share growth above 1.5x 3391.T's 1.23%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
187.81%
Debt growth far above 3391.T's 3.13%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-39.78%
We cut SG&A while 3391.T invests at 3.92%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.